Dr. Greg Marchand Named to the Fulbright Specialist Roster by the U.S. Department of State
FOR IMMEDIATE RELEASE
MESA, Ariz. — January 7, 2022
Critically important research from the Marchand Institute on the COVID19 virus’s affect on pregnancy is now available online. We would like to applaud the compassionate decision to make the full-text version available to all, free of charge from Elsevier Publishing. Our findings include a statistically significant increase in preterm deliveries in pregnancies affected by COVID19. Also, our findings cement the previously reported data that the extremely high maternal death rates, specifically those seen in 2003 SARS and 2012 MERS pandemics, are not being seen in the COVID19 pandemic.
The full text of the paper is available online here: https://www.sciencedirect.com/science/article/pii/S2666577821000472
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###
Related posts
